As prostate cancer progresses, androgen metabolism changes ... in CRPC and define how recurrent tumour cells utilise precursor steroids to survive in a low-testosterone (T) environment, a ...

Docetaxel plus prednisone as a first-line chemotherapy ... The identification of new drug resistance mechanisms and prostate cancer molecular subtypes based on genomic and proteomic analysis ...

NICE is unable to make a recommendation about the use in the NHS of niraparib (Zejula) with abiraterone acetate and prednisone for untreated hormone-relapsed metastatic prostate cancer in adults. This ...

Treatment may include steroids, radiation, or surgery. Hypercalcemia: Prostate cancer may result in hypercalcemia (an elevated level of calcium in the blood) due to the breakdown of bone from ...

Olaparib plus abiraterone improved survival vs placebo in BRCA-mutated metastatic castration-resistant prostate cancer.

A study found no significant HRQOL differences between Erleada-based therapies and ADT plus AAP for advanced castration-sensitive prostate cancer.